BioAge Labs
Price & Volume
Stats
See moreOpen | $5.12 |
Previous Close | $4.94 |
Day Range | $5.10-$5.34 |
52W Range | $2.88-$26.62 |
Market Cap | $183.1M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $3.8M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$7.2M |
Diluted EPS | -$6.81 |
News
See moreYahoo Finance • 13 hours ago
Leqembi® approved for the treatment of early Alzheimer's disease in Australia
Yahoo Finance • 14 days ago
FDA Approves BioArctic (OM:BIOA B) Lecanemab Injection For Alzheimer's
Yahoo Finance • 30 days ago
BioArctic signs $30 million deal with Novartis for brain drug delivery tech
About
CEO | Dr. Kristen Fortney Ph.D. |
Address | 1445A South 50th Street, Richmond, CA, United States, 94804 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 62 |
